stockportfolio.pro
TG Therapeutics, Inc. Gross Profit 2011–2025
TG Therapeutics, Inc. (TGTX) annual gross profit by fiscal year, computed from SEC filings. Compound growth +37.6%/yr over 14 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $515.57M | 83.7% | +77.5% |
| FY 2024 | $290.52M | 88.3% | +32.3% |
| FY 2023 | $219.53M | 94.0% | +8611.5% |
| FY 2022 | $2.52M | 90.5% | -57.3% |
| FY 2021 | $5.90M | 88.2% | — |
| FY 2020 | — | — | — |
| FY 2019 | — | — | — |
| FY 2018 | — | — | — |
| FY 2017 | — | — | — |
| FY 2016 | — | — | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
Source: TG Therapeutics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for TG Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTG Therapeutics, Inc. — frequently asked questions
What is TG Therapeutics, Inc.'s gross profit?
TG Therapeutics, Inc. (TGTX) reported gross profit of $515.57M for fiscal year 2025, per its SEC filings.
How has TG Therapeutics, Inc.'s gross profit changed over time?
Between fiscal 2011 and 2025, TGTX's gross profit grew at roughly 37.6% per year (compound annual rate), from $5.90M to $515.57M.
Where does this data come from?
Figures are computed from TG Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.